HZNP - Horizon Pharma Public Limited Company

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue981,120757,044296,955
Cost of Revenue393,272219,50278,753
Gross Profit587,848537,542218,202
Operating Expenses
Research Development60,70741,86517,460
Selling General and Administrative608,308440,305209,233
Non Recurring66,00066,00066,000
Total Operating Expenses---
Operating Income or Loss-147,16755,372-8,491
Income from Continuing Operations
Total Other Income/Expenses Net5,692-118,184-237,370
Earnings Before Interest and Taxes-141,475-62,812-245,861
Interest Expense86,61069,90023,826
Income Before Tax-228,085-132,712-269,687
Income Tax Expense-61,251-172,244-6,084
Minority Interest---
Net Income From Continuing Ops-166,834-38,092-292,993
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-166,83439,532-263,603
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-166,83439,532-263,603